SCHEMBL23477382

SCHEMBL23477382

CC(CN(C)C(C)C)OC(=O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2976274 0.73 PRKCA (0.44) PRKCA
SCHEMBL2479166 0.73 PRKCA (0.44) PRKCA
SCHEMBL2980891 0.73 PRKCA (0.44) PRKCA
SCHEMBL14848729 0.71 PRKCA (0.42) PRKCA
SCHEMBL12704911 0.71 PRKCA (0.39) PRKCA
SCHEMBL23198152 0.69 PRKCA (0.41) PRKCA
SCHEMBL25380718 0.69 PRKCA (0.46) PRKCA
SCHEMBL13073714 0.69 PRKCA (0.41) PRKCA
SCHEMBL16816620 0.69 PRKCA (0.41) PRKCA
SCHEMBL25380720 0.69 PRKCA (0.46) PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170043-A1 DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS CHINOOK THERAPEUTICS, INC. 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170043-A1 DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS STING1, TLR9, TLR3 PRKCA 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.